Direct intrauterine sampling: The IUMC endometrial sampler

Diagnostic Cytopathology

Volumn 17, Issue 2, 1997, Pages 153-159

  Tao, Liang Che ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Hospital   (United States)

Author keywords

Cytologic sampling device; Direct intrauterine sampling; Endometrial brushing; Endometrial cytology

Indexed keywords

CANCER CYTODIAGNOSIS; DEVICE; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; PRIORITY JOURNAL; REVIEW; SAMPLING;

ADENOCARCINOMA; ANIMALS; CYTODIAGNOSIS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTRUS; FEMALE; HUMANS; HYPERPLASIA;

EID: 0030877719     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199708)17:2<153::AID-DC13>3.0.CO;2-F     Document Type: Review

References (18)

1. Cancer Facts and Figures - 1996. Atlanta, GA: American Cancer Society. 1996:7.
2. Elwood MJ, Cole P, Rothman KJ. Epidemiology of endometrial cancer. J Natl Cancer Inst 1977;59:1055-1060.
3. Fox H, Sen DK, A controlled study of the constitutional stigmata of endometrial adenocarcinoma. Br J Cancer 1970;24:30-36.
4. Judd HL, Davidson BJ, Frumar AM. Serum androgens in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 1980;136:859-871.
5. Siiteri PK. Steroid hormones and endometrial cancer. Cancer Res 1978;38:4360-4366.
6. Silverberg SG, Mullen D, Faraci JA. Endometrial carcinoma: clinical-pathologic comparison of cases in postmenopausal women receiving and not receiving exogenous estrogens. Cancer 1980;45:3014-3026.
7. Bamford DS, Hall EW, Newman MR. The Isaac endometrial cell sampler: an evaluation in 100 patients with postmenopausal bleeding. Acta Cytol 1984;28:101-104.
8. Crow J, Gordon H, Hudson E. An assessment of the Mi-Mark endometrial sampler technique. J Clin Pathol 1980;33:72-80.
9. Ferenezy A, Gelfland MM. Outpatient endometrial sampling with Endocyte: comparative study of its effectiveness with endometrial biopsy. Obstet Gynecol 1984;63:295-302.
10. Palermo V. Interpretation of endometrium obtained by the Endo-Pap sampler and a clinical study of its use. Diagn Cytopathol 1985;1:5-12.
11. Tao LC. Cytopathology of the endometrium: direct intrauterine sampling. Chicago: ASCP Press, 1993.
12. Koss LG, Schreiber K, Oberlander SG. Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstet Gynecol 1984;64:1-11.
13. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 1992;399:1-15, 71-85.
14. National Surgical Adjuvant Breast and Bowel Project. NSABP protocol P-1: a clinical trial to determine the worth of tamoxifen for preventing breast cancer Pittsburgh. PA. 1992.
15. Cohen I, Rosen DJD, Shapira J. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynecol 1993;100:567-570.
16. Seoud MAF, Johnson J, Weed J Jr. Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 1993;82:165-169.
17. Eschenbach D, Rosene K, Tomkins LS. Endometrial cultures obtained by a triple lumen method from afebrile and febrile postpartum women. J Infect Dis 1986;6:1038-1045.
18. Tao LC. Cytomorphologic appearances of normal endometrial cells during different phases of the menstrual cycle: a cytologic approach to endometrial dating. Diagn Cytopathol 1995;13:95-102.